Skip to Content
Morningstar

Medtronic PLC MDT

Morningstar Rating
Unlock
Stock XNYS Rating as of
$79.99 +0.72 (0.91%)
View Full Chart
As of Delayed Price Pre-Open: $80.01 +0.02
Unlock Our Analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Medtronic Earnings: Recently Approved New Products Should Support Growth Into Fiscal 2025

Debbie Wang

Medtronic posted strong fiscal 2024 second-quarter results that put it on track to meet our full-year expectations, and we’re leaving our $112 fair value estimate unchanged. We think this quarter demonstrated more progress on the firm's larger objective of matching market growth. Organic revenue growth of 5% was fueled by strength in stent grafts for abdominal aortic aneurysm, the digital Aible system for spine procedures, and GI Genius, which incorporates artificial intelligence to better detect polyps during colonoscopy. Importantly, Medtronic recently obtained regulatory approval on several emerging technologies that we see as key growth drivers. These innovative new products reinforce the intangible assets that support Medtronic’s wide economic moat.

Read Full Report

Price vs Fair Value

View History
MDT is trading at a 29% discount.
Price
$79.99
Fair Value
$297.00
Uncertainty
Medium
1-Star Price
$354.20
5-Star Price
$18.70
Economic Moat
Xwcf
Capital Allocation
Hwljtmqx

Bulls Say, Bears Say

Bulls

Medtronic has historically held roughly 50% share in its core heart devices. It's also the market leader in spinal products, insulin pumps, and neuromodulators for chronic pain.

Bears

As smaller firms introduce new insulin pump technology, Medtronic may face a stiffer fight to maintain its leadership in this arena.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MDT is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$79.27
Day Range
$78.76–80.08
52-Week Range
$68.84–92.02
Bid/Ask
$79.66 / $80.78
Market Cap
$106.40 Bil
Volume/Avg
31 / 6.7 Mil

Key Statistics

Price/Earnings (Normalized)
14.79
Price/Sales
3.34
Dividend Yield
3.43%
Dividend Yield (Forward)
3.45%
Total Yield
3.65%

Company Profile

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Large Value
Total Number of Employees
95,000
Website
https://www.medtronic.com

Competitors

Valuation

View More
Metric
MDT
BSX
JNJ
Price/Earnings (Normalized)
 14.7928.7915.09
Price/Book Value
 2.074.355.35
Price/Sales
 3.345.944.74
Price/Cash Flow
 14.3929.9018.61
Price/Earnings
MDT
BSX
JNJ

Financial Strength

Metric
MDT
BSX
JNJ
Quick Ratio
 1.420.670.86
Current Ratio
 2.291.421.21
Interest Coverage
 8.968.0720.16
Quick Ratio
MDT
BSX
JNJ

Profitability

Metric
MDT
BSX
JNJ
Return on Assets (Normalized)
 7.71%8.56%14.22%
Return on Equity (Normalized)
 13.75%15.65%35.35%
Return on Invested Capital (Normalized)
 9.80%10.89%22.60%
Return on Assets
MDT
BSX
JNJ

Medical Devices Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesPnfqk$182.1 Bil
SYK
Stryker CorpYxsf$113.1 Bil
BSX
Boston Scientific CorpWkksmh$82.2 Bil
DXCM
DexCom IncTjbq$44.5 Bil
EW
Edwards Lifesciences CorpXdhnkh$41.5 Bil
ZBH
Zimmer Biomet Holdings IncQyr$24.7 Bil
PHG
Koninklijke Philips NV ADRLnvcgfj$18.9 Bil
ALGN
Align Technology IncHylmrw$16.9 Bil
PODD
Insulet CorpSjxqr$13.4 Bil